Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)

Sage Therapeutics Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,577	2,823	3,429	3,544	5,056	2,735
Market Cap Growth	-1.40%	-17.66%	-3.25%	-29.90%	84.84%	9.21%
Enterprise Value	4,300	3,456	3,965	3,814	5,742	3,210
Last Close Price	6.47	5.09	6.09	6.33	8.91	4.96
PE Ratio	116.31	55.88	78.72	-	843.33	93.55
PS Ratio	2.03	1.45	1.66	1.81	3.15	1.93
PB Ratio	2.19	1.74	2.11	2.20	2.84	1.79
P/TBV Ratio	2.88	2.28	2.77	2.87	3.83	2.47
P/FCF Ratio	72.98	-	5673.80	-	83.46	3529.88
P/OCF Ratio	41.03	-	78.40	-	50.74	37.25
EV/Sales Ratio	2.44	1.78	1.92	1.95	3.58	2.27
EV/EBITDA Ratio	34.39	27.17	31.16	96.86	33.91	27.29
EV/EBIT Ratio	71.01	45.53	52.21	-	45.81	42.12
EV/FCF Ratio	87.72	-	6560.68	-	94.77	4142.80
Debt / Equity Ratio	0.66	0.63	0.48	0.41	0.69	0.87
Debt / EBITDA Ratio	8.59	7.30	5.42	12.08	6.71	11.26
Debt / FCF Ratio	21.90	-	1290.72	-	20.22	1709.07
Asset Turnover	0.49	0.55	0.58	0.53	0.45	0.45
Inventory Turnover	3.19	3.50	3.33	3.59	3.14	3.23
Quick Ratio	0.86	0.80	0.88	0.86	0.89	0.97
Current Ratio	1.13	1.06	1.21	1.18	1.18	1.25
Return on Equity (ROE)	2.18%	3.29%	2.77%	-4.47%	0.41%	1.86%
Return on Assets (ROA)	1.05%	1.34%	1.32%	-0.13%	2.18%	1.51%
Return on Capital (ROIC)	1.44%	1.88%	2.03%	-0.19%	2.67%	1.75%
Return on Capital Employed (ROCE)	3.40%	4.50%	3.90%	-	5.90%	4.00%
Earnings Yield	0.86%	1.79%	1.27%	-2.04%	0.12%	1.07%
FCF Yield	1.37%	-2.72%	0.02%	-5.39%	1.20%	0.03%
Dividend Yield	0.42%	0.55%	0.29%	-	0.11%	0.32%
Payout Ratio	235.61%	136.70%	115.18%	-	1410.34%	223.89%
Buyback Yield / Dilution	1.25%	1.12%	-0.07%	-0.36%	-2.52%	1.68%
Total Shareholder Return	1.67%	1.67%	0.22%	-0.36%	-2.40%	2.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.